Itraconazole/posaconazole/voriconazole

Itraconazole/posaconazole/voriconazole Reactions 1704, p214 - 2 Jun 2018 Itraconazole/posaconazole/ voriconazole Various toxicities: case report A woman in her late 60s [age not clearly stated] developed hives during treatment with itraconazole, alopecia during treatment with voriconazole and pseudo-hyperalsosteronism during treatment with posaconazole. Additionally, she also developed bilateral pitting pedal oedema secondary to itraconazole and posaconazole therapy [routes not stated; not all dosages and duration of treatments to reaction onsets stated]. The woman, who had a history of diabetes mellitus and multiple sclerosis, was diagnosed with disseminated histoplasmosis. For the treatment, she started receiving itraconazole, but she developed hives. Thereafter, her therapy was switched to voriconazole, which resulted in alopecia. She requested a change in therapy. Therefore, she started receiving posaconazole 300mg once daily extended release tablet formulation. After four months of starting posaconazole therapy, she developed bilateral pitting pedal oedema, orthopnoea and shortness of breath on exertion. A CT scan showed new large bilateral pleural effusion. A transthoracic echocardiogram (TTE) showed grade II diastolic dysfunction with normal ejection fraction, dilation of right ventricle and atrium along with severe functional mitral regurgitation. Additionally, her corrected QT interval was prolonged to 520ms. The woman’s posaconazole therapy was withheld. Considering the presentation of congestive heart failure, she was treated with furosemide. On initial examination, she was noted to be hypertensive. The laboratory tests showed hypokalaemia and mild alkalosis. The newly developed hypokalaemia and systemic hypertension were difficult to manage. Therefore, her treatment was started with four antihypertensives and strong potassium supplementation. Considering the pattern of hypokalaemia and hypertension, morning renin and aldosterone levels were checked. Morning cortisol level was 11.3 µg/dL, morning renin level was <3.0 and aldosterone level was <0.2. Considering the investigations, a diagnosis of pseudo-hyperaldosteronism was made. Over the subsequent 6 weeks, oedema of the lower extremity was resolved. Her treatment with diuretics and most of the antihypertensives were stopped, within 4 weeks of hospital admission. A repeat TTE after six weeks of hospitalisation showed normal right atrium and ventricle. Only mild to moderate mitral regurgitation was observed. Subsequently, a complete resolution of hypokalaemia and hypertension were also observed. Author comment: "This syndrome of pseudohyperaldosteronism is similar to that seen in the patient described in this report." "Resolution of newly developed systemic hypertension, hypokalemia, and edema after withholding posaconazole suggests that posaconazole was the cause of these problems." "Itraconazole, its metabolite hydroxyitraconazole, and posaconazole. . .may contribute to the peripheral edema and hypokalemia". Kuriakose K, et al. Posaconazole-induced pseudohyperaldosteronism. Antimicrobial Agents and Chemotherapy 62: e02130-17, No. 5, May 2018. Available from: URL: http://doi.org/10.1128/AAC.02130-17 - USA 803323503 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Itraconazole/posaconazole/voriconazole

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/itraconazole-posaconazole-voriconazole-inF95ETiUE
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46857-3
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p214 - 2 Jun 2018 Itraconazole/posaconazole/ voriconazole Various toxicities: case report A woman in her late 60s [age not clearly stated] developed hives during treatment with itraconazole, alopecia during treatment with voriconazole and pseudo-hyperalsosteronism during treatment with posaconazole. Additionally, she also developed bilateral pitting pedal oedema secondary to itraconazole and posaconazole therapy [routes not stated; not all dosages and duration of treatments to reaction onsets stated]. The woman, who had a history of diabetes mellitus and multiple sclerosis, was diagnosed with disseminated histoplasmosis. For the treatment, she started receiving itraconazole, but she developed hives. Thereafter, her therapy was switched to voriconazole, which resulted in alopecia. She requested a change in therapy. Therefore, she started receiving posaconazole 300mg once daily extended release tablet formulation. After four months of starting posaconazole therapy, she developed bilateral pitting pedal oedema, orthopnoea and shortness of breath on exertion. A CT scan showed new large bilateral pleural effusion. A transthoracic echocardiogram (TTE) showed grade II diastolic dysfunction with normal ejection fraction, dilation of right ventricle and atrium along with severe functional mitral regurgitation. Additionally, her corrected QT interval was prolonged to 520ms. The woman’s posaconazole therapy was withheld. Considering the presentation of congestive heart failure, she was treated with furosemide. On initial examination, she was noted to be hypertensive. The laboratory tests showed hypokalaemia and mild alkalosis. The newly developed hypokalaemia and systemic hypertension were difficult to manage. Therefore, her treatment was started with four antihypertensives and strong potassium supplementation. Considering the pattern of hypokalaemia and hypertension, morning renin and aldosterone levels were checked. Morning cortisol level was 11.3 µg/dL, morning renin level was <3.0 and aldosterone level was <0.2. Considering the investigations, a diagnosis of pseudo-hyperaldosteronism was made. Over the subsequent 6 weeks, oedema of the lower extremity was resolved. Her treatment with diuretics and most of the antihypertensives were stopped, within 4 weeks of hospital admission. A repeat TTE after six weeks of hospitalisation showed normal right atrium and ventricle. Only mild to moderate mitral regurgitation was observed. Subsequently, a complete resolution of hypokalaemia and hypertension were also observed. Author comment: "This syndrome of pseudohyperaldosteronism is similar to that seen in the patient described in this report." "Resolution of newly developed systemic hypertension, hypokalemia, and edema after withholding posaconazole suggests that posaconazole was the cause of these problems." "Itraconazole, its metabolite hydroxyitraconazole, and posaconazole. . .may contribute to the peripheral edema and hypokalemia". Kuriakose K, et al. Posaconazole-induced pseudohyperaldosteronism. Antimicrobial Agents and Chemotherapy 62: e02130-17, No. 5, May 2018. Available from: URL: http://doi.org/10.1128/AAC.02130-17 - USA 803323503 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off